Company: PBH
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001295947-25-000039
Chunk: 0

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 3
Chunk 0
---
ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk

Our 2012 ABL Revolver is variable rate debt.  At September 30, 2025, the 2012 ABL Revolver had a zero balance and therefore none of our debt carried a variable rate of interest at September 30, 2025.  

Foreign Currency Exchange Rate Risk 

During the three and six months ended September 30, 2025, approximately 16.0% and 15.3%, respectively, of our gross revenues were denominated in currencies other than the U.S. Dollar.  During the three and six months ended September 30, 2024, approximately 15.3% and 14.5%, respectively, of our gross revenues were denominated in currencies other than the U.S. Dollar.  As such, we are exposed to transactions that are sensitive to foreign currency exchange rates. These transactions are

primarily with respect to the Canadian and Australian Dollars.

We performed a sensitivity analysis with respect to exchange rates for the three and six months ended September 30, 2025 and 2024.  Holding all other variables constant, and assuming a hypothetical 10.0% adverse change in foreign currency exchange rates, this analysis resulted in a less than 5.0% impact on pre-tax income of approximately $1.3 million for the three months ended September 30, 2025 and approximately $1.5 million for the six months ended September 30, 2025.  It represented a less than 5.0% impact on pre-tax income of approximately $1.8 million for the three months ended September 30, 2024 and $3.3 million for the six months ended September 30, 2024.